Feline infectious peritonitis (FIP) is a fatal disease in cats. The disease results from widespread viral replication in affected animals and an inadequate and harmful immune response to the virus. Currently, there is no effective treatment for this disease. Though therapies aimed at improving the immune response to this virus have shown some benefit, there is a need for an additional therapy to specifically inhibit virus growth in order to effect a successful treatment. Recently, ribonucleic acid (RNA) interference has been shown to be useful for treating virus infections. This antiviral mechanism results from the introduction of double stranded RNA into cells that specifically target the virus and thus lead to its destruction. This strategy has been used successfully in experimental models to treat Severe Acute Respiratory Disease (SARS), a virus that produces a disease similar to FIP in humans. In addition, this strategy has been shown to be effective against a feline virus, feline herpes virus.
Related blog articles:
May 2013: FIP treatment research: targeting viral replication
July 2013: Molecular basis of feline coronavirus pathogenesis
Dec 2013: How FIP affects the feline immune response
More on cat health:
Winn Feline Foundation Library
Find us on Facebook
Follow us on Twitter
Pin with us on Pinterest
Join us on Google+